Aileron Therapeutics Inc reported raising $30.1 Million in an initial SEC Form D filing, from an offering of $40 Million
Amount Raised
$30.1 Million
Round Type
Venture
WalthamBiotechnologyHealth CareTherapeuticsWho else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Rein Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Pulse Biosciences, Inc. raised $5M on February 15, 2017.
- IRulya Therapeutics Inc. raised $7.6M on February 14, 2017.
- Rezolute raised $3.4M (Seed) on February 14, 2017.
- AIM ImmunoTech raised $18K (Pre-Seed) on February 13, 2017.
- Ovid Therapeutics raised $26M on January 20, 2017.
- Rhythm Pharmaceuticals raised $20M on January 20, 2017.
Who to call at Rein Therapeutics, Inc., and when
A new round usually means Rein Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rein Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rein Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rein Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rein Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Rein Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.